<!DOCTYPE html>
<html>
  <head>
    <meta http-equiv="content-type" content="text/html; charset=UTF-8">
    <title>SPHK1</title>
  </head>
  <body style=" background-color: white;">
    <p style="background-color: white;"> </p>
    <div id="content-protein" class="entry-overview-content" style="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px; grid-column: 2 / auto; vertical-align: top; margin-top: 0px; padding-top: 0px; padding-left: 0.5rem; border-left: 4px solid #99c6d7; margin-left: 4px; box-sizing: border-box; color: #222222; font-family: Verdana,Arial,sans-serif; font-size: 13px; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: white;">
      <h1 property="name" style="font-weight: 700; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px; padding: 0px; font-family: Verdana, sans-serif; line-height: 1.2; margin: 0px; width: auto; font-size: 30px; color: rgb(0, 0, 0); display: inline;">
        <span style="color: rgb(0, 0, 0); font-family: Verdana, sans-serif; font-size: 30px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 700; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">Sphingosine
          kinase 1</span></h1>
    </div>
    <br>
    <p><img src="litemol_screenshot.png" alt="" title="p21_structure"
        width="45%"></p>
    <p><br>
    </p>
    <p style="margin: 0px; text-indent: 36px; background-color: white;"> <span
        style="color: rgb(34, 34, 34); font-family: Verdana, Arial, sans-serif; font-size: 13px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"><span
          style="color: black;"><font
            size="3"><span
              style="font-family: &quot;Helvetica Neue&quot;;">The
              reason why I chose SPHK1 was that I found SPHK1 is the
              target gene of hsa-miR-659 </span></font></span></span><span style="color: rgb(34, 34, 34); font-family: Verdana, Arial, sans-serif; font-size: 13px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"><span
          style="color: black;"><font
            size="3"><span
              style="font-family: &quot;Helvetica Neue&quot;;"><span
                style="color: rgb(34, 34, 34); font-family: Verdana, Arial, sans-serif; font-size: 13px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"><span
                  style="color: black;"><font
                    size="3"><span
                      style="font-family: &quot;Helvetica Neue&quot;;">
                      in my project study(Topic: Finding bladder cancer related
                      miRNA by GA based on miRNA expression and clinical data)</span></font></span></span>.
              Experiment revealed SPHK1 expression was upregulated in the
              bladder cancer and was correlated with histologic gradeand tumor
              stage. Patients with high expression of SPHK1 had reduced overall
              5-year survival rates, so I considered if we can find the ligand to target SPHK1 binding site may inhibit the tumor cell proliferation. <span style="color: #222222;"><span style="font-family: Verdana,Arial,sans-serif;">.</span></span></span></font></span></span></p>
    <p style="margin-top: 0px; margin-right: 0px; margin-bottom: 0px; text-indent: 36px; background-color: white;"><span
        style="color: rgb(34, 34, 34); font-family: Verdana, Arial, sans-serif; font-size: 13px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"><span
          style="color: black;"><font
            size="3"><span
              style="font-family: &quot;Helvetica Neue&quot;;"><span
                style="color: #222222;"><span
                  style="font-family: Verdana,Arial,sans-serif;"><br>
                </span></span></span></font></span></span></p>
    <p style="margin-top: 0px; margin-right: 0px; margin-bottom: 0px; text-indent: 36px; background-color: white;"><span
        property="text"
        style="font-weight: 400; font-style: Helvetica Neue; text-decoration: none; text-align: left; text-indent: 0px;">Catalyzes
        the phosphorylation of sphingosine to form sphingosine
        1-phosphate (SPP), a lipid mediator with both intra- and extracellular
        functions. Also acts on D-erythro-sphingosine and to a lesser extent
        sphinganine, but not other lipids, such as D,L-threo-dihydrosphingosine,
        N,N-dimethylsphingosine, diacylglycerol, ceramide, or
        phosphatidylinositol. In contrast to proapoptotic SPHK2, has a negative
        effect on intracellular ceramide levels, enhances cell growth and
        inhibits apoptosis. Involved in the regulation of inflammatory response
        and neuroinflammation. Via the product sphingosine 1-phosphate,
        stimulates TRAF2 E3 ubiquitin ligase activity, and promotes activation
        of NF-kappa-B in response to TNF signaling leading to IL17 secretion. In
        response to TNF and in parallel to NF-kappa-B activation, negatively
        regulates RANTES induction through p38 MAPK signaling pathway. Involved
        in endocytic membrane trafficking induced by sphingosine, recruited to
        dilate endosomes, also plays a role on later stages of endosomal
        maturation and membrane fusion independently of its kinase activity. In
        Purkinje cells, seems to be also involved in the regulation of
        autophagosome-lysosome fusion upon VEGFA. Has serine acetyltransferase
        activity on PTGS2/COX2 in an acetyl-CoA dependent manner. The
        acetyltransferase activity increases in presence of the kinase
        substrate, sphingosine. During neuroinflammation, through PTGS2
        acetylation, promotes neuronal secretion of specialized preresolving
        mediators (SPMs), especially 15-R-lipoxin A4, which results in an
        increase of phagocytic microglia.</span> <span style="color: rgb(34, 34, 34); font-family: Verdana, Arial, sans-serif; font-size: 13px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">.</span>
    </p>
    <p style="background-color: white;"><br>
    </p>
    <br>
    <span style="color: #8c6eb7; font-size: 20px; font-family: Verdana"><b>
        STITCH: Chemicalâ€“Protein Interactions</b></span><br>
    <p style="background-color: white;"> <img src="sphk1stit.png"
        alt=""
        title="sphk1_stitch"
        width="45%"></p>
    <span style="color: #8c6eb7; font-size: 20px"><b><span style="color: black;font-family: Verdana">Sequence</span><br>
      </b></span>
    <p style="background-color: white;"> </p>
    <pre class="sequence" style="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px; font-family: monospace,monospace; font-size: 14.04px; white-space: pre-wrap; overflow-wrap: break-word; padding: 29.5417px; border-width: 1px; border-style: dotted; overflow: auto; color: #222222; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: white;">        10         20         30         40         50<br
style="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px;">MDPAGGPRGV LPRPCRVLVL LNPRGGKGKA LQLFRSHVQP LLAEAEISFT <br
style="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px;">        60         70         80         90        100<br
style="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px;">LMLTERRNHA RELVRSEELG RWDALVVMSG DGLMHEVVNG LMERPDWETA <br
style="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px;">       110        120        130        140        150<br
style="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px;">IQKPLCSLPA GSGNALAASL NHYAGYEQVT NEDLLTNCTL LLCRRLLSPM <br
style="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px;">       160        170        180        190        200<br
style="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px;">NLLSLHTASG LRLFSVLSLA WGFIADVDLE SEKYRRLGEM RFTLGTFLRL <br
style="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px;">       210        220        230        240        250<br
style="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px;">AALRTYRGRL AYLPVGRVGS KTPASPVVVQ QGPVDAHLVP LEEPVPSHWT <br
style="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px;">       260        270        280        290        300<br
style="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px;">VVPDEDFVLV LALLHSHLGS EMFAAPMGRC AAGVMHLFYV RAGVSRAMLL <br
style="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px;">       310        320        330        340        350<br
style="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px;">RLFLAMEKGR HMEYECPYLV YVPVVAFRLE PKDGKGVFAV DGELMVSEAV <br
style="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px;">       360        370        380 <br
style="font-weight: 400; font-style: normal; text-decoration: none; text-align: left; text-indent: 0px;">QGQVHPNYFW MVSGCVEPPP SWKPQQMPPP EEPL        </pre>
    <p style="background-color: white;"> </p>
    <p style="background-color: white;"></p>
  </body>
</html>
